Glaukoma-MIGS devices

iStent Glaukoma

iStent inject is intended to provide safe and effective IOP reduction by addressing OAG at the primary site of resistance to outflow

iStent inject:

  • Re-establishes physiological outflow to significantly decrease IOP.
  • Reduces or eliminates drug burden.
  • Indicated for patients undergoing combination glaukoma/cataract surgery.
  • Developed by Glaukos Corporation, the corporate founder of Micro-Invasive Glaucoma Surgery (MIGS).


  • One of the smallest medical devices known to be implanted into humans.
  • Improves aqueous outflow to significantly reduce pressure (IOP).


  • Medical grade titanium.
  • Heparin coating.
  • 1 mm in length.
  • 0.3 mm in height.
  • 120 um lumen diameter.

ophthalmos glaukoma

The Stegmann Canal Ecpander

Controlled & Simplified Canaloplasty.

Subscribe to RSS - Glaukoma-MIGS devices